Literature DB >> 18701411

Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast.

Junzo Yamaguchi1, Hiroshi Ohtani, Kazukuni Nakamura, Isao Shimokawa, Takashi Kanematsu.   

Abstract

This study aimed to investigate whether adipose tissue invasion (ATI) of cancer cells at the tumor margin influenced lymph node status and prognosis in patients with invasive ductal carcinoma of the breast. Data for 245 patients with breast cancer with marginal ATI were clinicopathologically compared with data for 65 patients without ATI. We also examined the value of the combination of ATI and peritumoral lymphatic vessel invasion (LVI). The frequency of axillary lymph node metastases was 40.7% in patients with ATI (99/243) and 11.3% in patients without ATI (7/62; P<.0001), and ATI was an independent factor influencing nodal metastasis. Patients with ATI had a poorer prognosis than patients without ATI (10-year disease-free survival, 76% and 94%, respectively; P=.0323). In addition, patients without ATI or LVI had neither lymph node metastasis (n=52) nor recurrent disease (n=53). ATI is one of the biologic indicators of tumor aggressiveness.

Entities:  

Mesh:

Year:  2008        PMID: 18701411     DOI: 10.1309/MX6KKA1UNJ1YG8VN

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  28 in total

Review 1.  Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.

Authors:  Ernst Lengyel; Liza Makowski; John DiGiovanni; Mikhail G Kolonin
Journal:  Trends Cancer       Date:  2018-04-05

Review 2.  Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.

Authors:  Ying Xiong; Lindsay T McDonald; Dayvia L Russell; Ryan R Kelly; Katie R Wilson; Meenal Mehrotra; Adam C Soloff; Amanda C LaRue
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

Authors:  Simona Hefetz-Sela; Philipp E Scherer
Journal:  Pharmacol Ther       Date:  2013-01-24       Impact factor: 12.310

4.  Fatty acid composition in mammary adipose tissue measured by Gradient-echo Spectroscopic MRI and its association with breast cancers.

Authors:  Alana A Lewin; Pippa Storey; Melanie Moccaldi; Linda Moy; S Gene Kim
Journal:  Eur J Radiol       Date:  2019-05-01       Impact factor: 3.528

Review 5.  Obesity and cancer: at the crossroads of cellular metabolism and proliferation.

Authors:  Robert W O'Rourke
Journal:  Surg Obes Relat Dis       Date:  2014-08-27       Impact factor: 4.734

6.  Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.

Authors:  Nikki A Ford; Emily L Rossi; Kelsey Barnett; Peiying Yang; Laura W Bowers; Brandon H Hidaka; Bruce F Kimler; Susan E Carlson; Imad Shureiqi; Linda A deGraffenried; Carol J Fabian; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-22

7.  Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival.

Authors:  Sayaka Kuba; Hiroshi Ohtani; Junzo Yamaguchi; Hiroko Hayashi; Tatsuya Uga; Takashi Kanematsu; Isao Shimokawa
Journal:  Virchows Arch       Date:  2011-01-08       Impact factor: 4.064

Review 8.  Contribution of Adipose Tissue to Development of Cancer.

Authors:  Alyssa J Cozzo; Ashley M Fuller; Liza Makowski
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

Review 9.  White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions.

Authors:  Achinto Saha; Jill Hamilton-Reeves; John DiGiovanni
Journal:  Cancer Metastasis Rev       Date:  2022-08-04       Impact factor: 9.237

10.  Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.

Authors:  Wenlian Zhu; Susan Harvey; Katarzyna J Macura; David M Euhus; Dmitri Artemov
Journal:  Clin Breast Cancer       Date:  2016-07-28       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.